Part detail
Fentanyl Transdermal System
NDC00591 3214 72NSN6505-01-655-9607CAGE6LMB8
Fentanyl Transdermal System
Detailed description
NDC00591 3214 72 procurement notes
Fentanyl Transdermal System
Specifications
Reference data
Multi-line procurement
Sourcing more than one part?
Upload a bill of materials (BOM) or paste a list of part numbers — every line bundles into a single RFQ. No checkout, no payment.
Compliance
- AS9120:2025· Aerospace QMS
- ISO 9001:2015· Quality Management
- FAA AC 00-56B· Voluntary Industry Distributor Accreditation
- U.S. ONLY· Fulfillment
NSN Information for Part Number NDC00591 3214 72 with NSN 6505-01-655-9607, 6505016559607
Characteristics Data of NSN 6505-01-655-9607, 6505016559607
| MRC | Criteria | Characteristic |
|---|---|---|
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| FEAT | SPECIAL FEATURES | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 100 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (100 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH; STORE UP TO 20 C TO 25 C (68 F TO 77 F); STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE II |
| CSLZ | USUAL DOSE | 100 MCG/HOUR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | DURAGESIC-100 (FENTANYL TRANSDERMAL SYSTEM) 100MCG/HR, 5S |